Gisou Van Der Goot

Gisou Van Der Goot


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2015 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
MPMatteo Dal Peraro
Matteo Dal Peraro
GGGisou Van Der Goot
Gisou Van Der Goot

1 September 2006 in Cell
Verified
Journal Article
Closed access
LGLaure Gurcel
Laure Gurcel
LALaurence Abrami
Laurence Abrami
SGStephen Girardin
Stephen Girardin
JTJurg Tschopp
Jurg Tschopp
GGGisou Van Der Goot
Gisou Van Der Goot

27 January 2003 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
LALaurence Abrami
Laurence Abrami
Shihui LiuShihui Liu
Shihui Liu
PCPierre Cosson
Pierre Cosson
SLStephen H. Leppla
Stephen H. Leppla
GGGisou Van Der Goot
Gisou Van Der Goot
The protective antigen (PA) of the anthrax toxin binds to a cell surface receptor and thereby allows lethal factor (LF) to be taken up and exert its toxic effect in the cytoplasm. Here, we report that clustering of the anthrax toxin receptor (ATR) with heptameric PA or with an antibody sandwich causes its association to specialized cholesterol and glycosphingolipid-rich microdomains of the plasma membrane (lipid rafts). We find that although endocytosis of ATR is slow, clustering it into rafts either via PA heptamerization or using an antibody sandwich is necessary and sufficient to trigger efficient internalization and allow delivery of LF to the cytoplasm. Importantly, altering raft integrity using drugs prevented LF delivery and cleavage of cytosolic MAPK kinases, suggesting that lipid rafts could be therapeutic targets for drugs against anthrax. Moreover, we show that internalization of PA is dynamin and Eps15 dependent, indicating that the clathrin-dependent pathway is the major route of anthrax toxin entry into the cell. The present work illustrates that although the physiological role of the ATR is unknown, its trafficking properties, i.e., slow endocytosis as a monomer and rapid clathrin-mediated uptake on clustering, make it an ideal anthrax toxin receptor.

1 December 1991 in Nature
Verified
Journal Article
Closed access
GGGisou Van Der Goot
Gisou Van Der Goot
JGJ. M. González-Mañas
J. M. González-Mañas
JLJ. H. Lakey
J. H. Lakey
FPF. Pattus
F. Pattus

14 June 2006 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
JGJean Gruenberg
Jean Gruenberg
GGGisou Van Der Goot
Gisou Van Der Goot

15 July 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
DHDanielle L. Huffman
Danielle L. Huffman
LALaurence Abrami
Laurence Abrami
RSRoman Sasik
Roman Sasik
JCJacques Corbeil
Jacques Corbeil
GGGisou Van Der Goot
Gisou Van Der Goot
RARaffi V. Aroian
Raffi V. Aroian
Cytolytic pore-forming toxins are important for the virulence of many disease-causing bacteria. How target cells molecularly respond to these toxins and whether or not they can mount a defense are poorly understood. By using microarrays, we demonstrate that the nematode Caenorhabditis elegans responds robustly to Cry5B, a member of the pore-forming Crystal toxin family made by Bacillus thuringiensis . This genomic response is distinct from that seen with a different stressor, the heavy metal cadmium. A p38 mitogen-activated protein kinase (MAPK) kinase and a c-Jun N-terminal-like MAPK are both transcriptionally up-regulated by Cry5B. Moreover, both MAPK pathways are functionally important because elimination of either leads to animals that are ( i ) hypersensitive to a low, chronic dose of toxin and ( ii ) hypersensitive to a high, brief dose of toxin such that the animal might naturally encounter in the wild. These results extend to mammalian cells because inhibition of p38 results in the hypersensitivity of baby hamster kidney cells to aerolysin, a pore-forming toxin that targets humans. Furthermore, we identify two downstream transcriptional targets of the p38 MAPK pathway, ttm-1 and ttm-2 , that are required for defense against Cry5B. Our data demonstrate that cells defend against pore-forming toxins by means of conserved MAPK pathways.